Monding, Mark Gerald R.

HRN: 23-35-01  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/14/2023
CEFTRIAXONE 1G (VIAL)
07/14/2023
07/20/2023
IV
2g
OD
Acute Pancreatitis
Waiting Final Action 
07/14/2023
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
07/14/2023
07/20/2023
IV
500 Mg
Q8H
Acute Pancreatitis
Waiting Final Action 
07/18/2023
AZITHROMYCIN 500MG TABLET (TAB)
07/18/2023
07/22/2023
PO
500MG
Od
CAP MR
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

 Indication:

              

 Type of Infection:

                             

           

 Compliance to guidelines:



 Initial appropriateness:



 If inappropriate:

           

 Final appropriateness:



 If inappropriate:

              

 Overall appropriateness: